J. Goldman & CO LP Rain Therapeutics Inc. Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

A detailed history of J. Goldman & CO LP transactions in Rain Therapeutics Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 40,500 shares of RAIN stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
40,500
Holding current value
$0
% of portfolio
0.01%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding RAIN

# of Institutions
3
Shares Held
122K
Call Options Held
0
Put Options Held
0
View Full List

About Rain Therapeutics Inc.

RAIN Quotes by TradingView
  • Ticker RAIN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,837,400
  • Description
  • Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...
More about RAIN
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email